LivaNova Q2 revenue $294M (+16% CC); raises FY guidance; adjusted EPS $0.78

LivaNova PLC

2023-Q2 EPS reported $0.16 revenue$557,300,000

Q2 revenue $293.9M, up 15.6% reported and 16.4% constant currency YoY.
GAAP diluted EPS $0.02; adjusted diluted EPS $0.78.
Full-year 2023 guidance raised (specifics not detailed in excerpt).
Randomized 150th patient in RECOVER bipolar depression study; interim analyses begun.
Stephanie Bolton named President of Global Epilepsy effective May 12.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

LivaNova PLC reported the quarter ended June 30, 2023 results: revenue $293.9 million. Guidance raised.

Period: the quarter ended June 30, 2023
Revenue: $293.9 million
Guidance: raised
Result: reported results

Exact text from the filing

technology company, today reported results for the quarter ended June 30, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights 1 • Second-quarter revenue of $293.9 million increased 15.6% on a reported basis and increased 16.4% on a constant-currency basis, as compared to the prior-year period • Second quarter U.S. GAAP diluted earnings per share

View on SEC.gov

Browse all earnings releases →

LivaNova PLC filing history →

Source: SEC EDGAR

accession 0001639691-23-000070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.